REGENXBIO Inc. (RGNX) Net margin 2016–2025
REGENXBIO Inc. (RGNX) net profit margin by fiscal year — reported net income divided by reported revenue.
-113.8%FY2025 · since FY2016: -1372.1% → -113.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -113.8% | +158.8 pp |
| FY2024 | -272.5% | +19.4 pp |
| FY2023 | -292.0% | -43.3 pp |
| FY2022 | -248.7% | -275.9 pp |
| FY2021 | 27.2% | +99.2 pp |
| FY2020 | -72.0% | +196.9 pp |
| FY2019 | -268.9% | -314.6 pp |
| FY2018 | 45.7% | +749.8 pp |
| FY2017 | -704.0% | +668.1 pp |
| FY2016 | -1372.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice